Logo image
Recurrence patterns after complex multimodality therapy and hepatic arterial infusion for colorectal liver metastases: A reflection of biology and technique
Journal article   Peer reviewed

Recurrence patterns after complex multimodality therapy and hepatic arterial infusion for colorectal liver metastases: A reflection of biology and technique

Matthew C. Hernandez, Darrell Fan, Jaideep Sandhu, Kelly Mahuron, Jonathan Kessler, Mustafa Raoof, Marwan Fakih, Gagandeep Singh, Yuman Fong and Laleh G. Melstrom
Journal of Surgical Oncology, Vol.129(7)
2024

Abstract

Aged Antineoplastic Combined Chemotherapy Protocols Colorectal Neoplasms Combined Modality Therapy Female Follow-Up Studies Hepatectomy Hepatic Artery Humans Infusions, Intra-Arterial Liver Neoplasms Male Middle Aged Neoplasm Recurrence, Local Prognosis Retrospective Studies Survival Rate antineoplastic agent floxuridine adult aged Article cancer combination chemotherapy cancer patient cancer recurrence cancer surgery cancer survival cohort analysis colorectal liver metastasis controlled study female hepatectomy human major clinical study male microwave thermotherapy multimodality cancer therapy overall survival postoperative complication systemic therapy colorectal tumor follow up hepatectomy hepatic artery intraarterial drug administration liver tumor middle aged multimodality cancer therapy pathology procedures prognosis retrospective study surgery survival rate therapy tumor recurrence
Background and Methods: We characterized colorectal liver metastasis recurrence and survival patterns after surgical resection and intraoperative ablation ± hepatic arterial infusion pump (HAIP) placement. We estimated patterns of recurrence and survival in patients undergoing contemporary multimodal treatments. Between 2017 and 2021, patient, tumor characteristics, and recurrence data were collected. Primary outcomes included recurrence patterns and survival data based on operative intervention. Results: There were 184 patients who underwent hepatectomy and intraoperative ablation. Sixty patients (32.6%) underwent HAIP placement. A total of 513 metastases were ablated, median total of 2 ablations per patient. Median time to recurrence was 31 [22–40] months. Recurrence patterns included tumor at ablative margin on first scheduled postoperative imaging (8, 4.3%), local tumor recurrence at ablative site (69, 37.5%), and non-ablated liver tumor recurrence (38, 20.6%). In patients who underwent HAIP placement, the rate of liver recurrence was reduced (45% vs 70.9%, p = 0.0001). Median overall survival was 64 [41-58] months and prolonged survival was associated with HAIP treatment (85 [66–109] vs 60 [51–70] months. Conclusions and Discussion: Hepatic recurrence is common and combination of intraoperative ablation and HAIP treatments were associated with prolonged survival. These data may reflect patient selection however, future work will clarify preoperative tumor and patient characteristics that may better predict recurrence expectations. © 2024 Wiley Periodicals LLC.

Metrics

8 Record Views

Details

Logo image